ConductScience.org, home

Paper34366147

Cellular senescence at the crossroads of inflammation and Alzheimer's disease.

Guerrero A and 2 others. Trends Neurosci, 2021. Cited by 200 papers, by iCite.

Cite this record

ConductScience Library. Cellular senescence at the crossroads of inflammation and Alzheimer's disease. Papers, record 34366147. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34366147

Download JSON
Disease
Alzheimer disease441 drugs
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cellular senescence at the crossroads of inflammation and Alzheimer's disease.
PubMed
Journal
Trends Neurosci
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
200
iCite
Relative citation ratio, by iCite
12
iCite
Revised in PubMed
2021-09-27
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Guerrero AAna
2De Strooper BBart
3Arancibia-Cárcamo ILI Lorena

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alzheimer DiseaseMajor topic
Aged
Aging
Cellular Senescence
Humans
Inflammation
Phenotype

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Medical Research CouncilUnited KingdomPubMed

Source PubMed

Download CSV of grants

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT04685590Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD) StudyDerived from the trialYesClinicalTrials.gov
NCT04785300ALSENLITE: Senolytics for Alzheimer's DiseaseDerived from the trialYesClinicalTrials.gov

Download CSV of trials

Cited by138

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 200 citations.

PMIDTitleJournalYearIn PapersSource
42939272Brain Aging and Cellular Senescence Trigger Neuroimmunological Dysregulation and Neurodegeneration.Brain Sci2026https://conductscience.org/library/papers/42939272PubMed
42861725Paracrine bone-derived senescent secretome is associated with spatially patterned extracellular matrix remodeling and altered biomechanics in human brain organoids.Stem Cells2026https://conductscience.org/library/papers/42861725PubMed
42680931Closing the gap in aging science: unlocking the potential of nanoparticles in senescence therapy.Biogerontology2026https://conductscience.org/library/papers/42680931PubMed
42654174Food-Derived Omega-3 Fatty Acids and Cognitive Aging: Integrating Nutritional Neuroscience and Geroscience.Nutrients2026https://conductscience.org/library/papers/42654174PubMed
42552384A reproducible three-dimensional model of human brain tissue to investigate physiological and disease-associated microglia phenotypes.Nat Neurosci2026https://conductscience.org/library/papers/42552384PubMed
42446473Multilayer Proteome and Metabolome-Based Validation Uncovers Combined Regulatory Roles and Predictive Values of 6 RNA Modifications and Cellular Senescence in Alzheimer's Disease.CNS Neurosci Ther2026https://conductscience.org/library/papers/42446473PubMed
42420256Could the cognitive benefits of amyloid-beta clearance grow in time for Alzheimer's disease?Transl Psychiatry2026https://conductscience.org/library/papers/42420256PubMed
42412302Study on the Effects and Mechanisms of Resveratrol in Improving Cognitive Impairment in Aβ1-42-Induced Alzheimer's Disease Model Mice.J Neuroimmune Pharmacol2026https://conductscience.org/library/papers/42412302PubMed
42324173Senescent Human Liver Endothelial Cells Mediate CD4+ T Cell Recruitment via ICOSL.Immunology2026https://conductscience.org/library/papers/42324173PubMed
42268464Advances in anti-tau therapeutics for alzheimer's disease: immunotherapy, gene modulation, and combination approaches.Mol Biol Rep2026https://conductscience.org/library/papers/42268464PubMed
42081929uPAR exhibits age- and region-dependent expression in the brains of mice with Alzheimer's disease-like pathology.Brain Res2026https://conductscience.org/library/papers/42081929PubMed
42072300Cellular Senescence in Neurodegeneration: From Cell Types to Therapeutic Opportunities.Biomedicines2026https://conductscience.org/library/papers/42072300PubMed
42057007PTP1B in astrocytes drives pathogen-induced neurodegeneration.J Neuroinflammation2026https://conductscience.org/library/papers/42057007PubMed
41870677Senescence as a Central Node in Alzheimer's Disease: Molecular Triggers, Cellular Effectors, and RNA-Based Interventions.Neurochem Res2026https://conductscience.org/library/papers/41870677PubMed
41851074Identification of plasma biomarkers in lipid metabolism for accurate prediction of Alzheimer's disease.Transl Psychiatry2026https://conductscience.org/library/papers/41851074PubMed
41526954Promoting the nuclear retention of HMGB1 attenuates astrocyte senescence.J Neuroinflammation2026https://conductscience.org/library/papers/41526954PubMed
41489638Cell senescence-related pathogenic genes in sleep disorders: a multi-omics Mendelian randomization study.Eur Arch Psychiatry Clin Neurosci2026https://conductscience.org/library/papers/41489638PubMed
41445867Mapping microglial mechanisms in Alzheimer's disease: a comprehensive analysis.Exp Biol Med (Maywood)2025https://conductscience.org/library/papers/41445867PubMed
41441223Senotherapeutics for Brain Aging Management.Neurol Int2025https://conductscience.org/library/papers/41441223PubMed
41272336Dual Mechanisms of Cognitive Function and Pathological Improvements by the Selective S1PR1/5 Modulator Siponimod in 3xTg-AD Mice.Mol Neurobiol2025https://conductscience.org/library/papers/41272336PubMed

See all 138 cited byDownload CSV of cited by

Drugs3

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targetsSource
DASATINIB ANHYDROUSCHEMBL1421Derived from the trial1https://conductscience.org/library/drugs/CHEMBL1421ChEMBL
QUERCETINCHEMBL50Derived from the trial2https://conductscience.org/library/drugs/CHEMBL50ChEMBL
DASATINIBCHEMBL5416410Derived from the trial1https://conductscience.org/library/drugs/CHEMBL5416410ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • References
  • Genes
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34366147

GET https://conductscience.org/api/papers/v1/34366147/cited_by?page=2